Sentinel Surveillance of Substance-Related Poisonings in Canada: Spotlight on Cannabis

Substance-related poisonings and injuries in Canada have received increasing attention in recent years due to emerging public health concerns, such as the opioid overdose crisis, the introduction of synthetic cannabinoids to the illicit market and the emergence of electronic cigarettes/vaping products on the Canadian market. Furthermore, there has been a general increase in substance-related hospitalizations and deaths during the COVID-19 pandemic compared to the same period in 2019.

This data blog presents statistics on poisonings from six select substances, namely alcohol, cannabis, methamphetamine, opioids, cocaine and e-cigarette/vaping products. It is the fourth data blog in a series presenting statistics on substance-related poisonings reported by the Canadian Hospitals Injury Reporting and Prevention Program (CHIRPP), and features a spotlight on cannabis.

CHIRPP is an injury and poisoning sentinel surveillance system currently operating in the emergency departments of 11 pediatric and ten general hospitals across Canada. It collects patients’ accounts of pre-event injury circumstances (“What happened?”), and clinical information is added to the data collection form by hospital staff. CHIRPP captures a more complete picture of the injury event than hospital administrative or mortality data alone, and also identifies less serious injury cases that do not require hospitalization.

To read the complete article, including all relevant data presented, click here: https://health-infobase.canada.ca/datalab/poisonings-surveillance/cannabis.html?utm_source=CSIMS&utm_medium=Email&utm_campaign=launch_substance_poisonings_spotlight_on_cannabis_January_2022_ENG

For more information on the International Academy on the Science and Impact of Cannabis, and to join, please visit www.IASIC1.org.

Visit the IASIC Library here (https://iasic1.org/library/). The IASIC Library is intended as a user-friendly reference of the published medical literature.

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Related Posts

IASIC Speaker Series Presents  Cannabis and Mental Health

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Placebo Effect a Major Driver of Pain Reduction in Cannabis Trials

A strong placebo response may be largely responsible for the significant pain reduction observed in clinical trials of cannabis-based therapies, results of a new meta-analysis suggest. Investigators found that while the effect size of cannabinoids on pain intensity was significant, the placebo effect was about the same. “The data from the present meta-analysis, including 1459

Trends in Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration, 2005–2019

Since 2005, diagnoses of cannabis use disorder have increased substantially among VHA patients, as they have in the general population and other patient populations. Possible explanations warranting investigation include decreasing perception of risk, changing laws, increasing cannabis potency, stressors related to growing socioeconomic inequality, and use of cannabis to self-treat pain. Clinicians and the public

Cannabis legalization and cannabis-involved pregnancy hospitalizations in Colorado

The primary objective of this study was to evaluate the association between presence of recreational cannabis dispensaries and prevalence of cannabis-involved pregnancy hospitalizations in Colorado. This was a retrospective cohort study of pregnancy-related hospitalizations co-coded with cannabis diagnosis codes in the Colorado Hospital Association from January 1, 2011, through December 31, 2018 (recreational cannabis began

Scroll to Top